Literature DB >> 8895878

Pituitary adenylate cyclase activating peptide expression in the rat dorsal root ganglia: up-regulation after peripheral nerve injury.

Y Z Zhang1, J Hannibal, Q Zhao, K Moller, N Danielsen, J Fahrenkrug, F Sundler.   

Abstract

Pituitary adenylate cyclase activating peptide (PACAP) is expressed in a population of capsaicin-sensitive primary sensory neurons of small to medium size in the rat. In the present report we have examined the effect of sciatic nerve injury (unilateral transection) on PACAP expression (immunocytochemistry, radioimmunoassay, in situ hybridization and northern blot analysis) in dorsal root ganglia at the lumbar level and on immunoreactive PACAP in the spinal cord and in the sciatic nerve stump. For comparison, calcitonin gene-related peptide was examined. In dorsal root ganglia of the intact side immunoreactive PACAP and PACAP messenger RNA were localised to a population of nerve cell bodies of small to medium size. In dorsal root ganglia on the injured side, PACAP-immunoreactive nerve cell bodies were more numerous and PACAP messenger RNA was considerably more abundant as studied 14 days after sciatic nerve transection. By contrast, calcitonin gene-related peptide-containing nerve cell bodies were numerous and rich in calcitonin gene-related peptide messenger RNA in dorsal root ganglia on the intact side, while after transection both the number of immunoreactive nerve cell bodies and their content of messenger RNA were markedly reduced. There were indications of axotomy-induced expression of PACAP messenger RNA in larger neurons. In the dorsal horn of the spinal cord on the intact side PACAP and calcitonin gene-related peptide-immunoreactive fibres were densely accumulated in the superficial layers. On the transected side the densities of both PACAP and calcitonin gene-related peptide-immunoreactive nerve fibres were reduced in the medial part. The data obtained indicate a marked up-regulation of PACAP in sensory neurons following peripheral nerve injury. Since PACAP depresses a C-fibre evoked flexion reflex, this may have implications for sensory transmission. Further, in view of the known promoting effects of PACAP on neuronal survival and differentiation and non-neuronal cell growth as well as its proinflammatory effects a role of PACAP in the neuronal and periaxonal tissue restoration after injury is not inconceivable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895878     DOI: 10.1016/0306-4522(96)00168-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

1.  Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitors.

Authors:  M Lee; V Lelievre; P Zhao; M Torres; W Rodriguez; J Y Byun; S Doshi; Y Ioffe; G Gupta; A E de los Monteros; J de Vellis; J Waschek
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Role for pituitary adenylate cyclase activating polypeptide in cystitis-induced plasticity of micturition reflexes.

Authors:  Karen M Braas; Victor May; Peter Zvara; Bernhard Nausch; Jan Kliment; J Dana Dunleavy; Mark T Nelson; Margaret A Vizzard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-12-01       Impact factor: 3.619

3.  Bladder dysfunction and altered somatic sensitivity in PACAP-/- mice.

Authors:  Victor May; Margaret A Vizzard
Journal:  J Urol       Date:  2010-02       Impact factor: 7.450

4.  Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.

Authors:  W K Kim; Y Kan; D Ganea; R P Hart; I Gozes; G M Jonakait
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

5.  Identification of pituitary adenylate cyclase-activating polypeptide1-38-binding factor in human plasma, as ceruloplasmin.

Authors:  J W Tams; A H Johnsen; J Fahrenkrug
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

6.  Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.

Authors:  A Tamas; K Szabadfi; A Nemeth; B Fulop; P Kiss; T Atlasz; R Gabriel; H Hashimoto; A Baba; N Shintani; Zs Helyes; D Reglodi
Journal:  Neurotox Res       Date:  2011-12-28       Impact factor: 3.911

7.  Use of laser microdissection in the investigation of facial motoneuron and neuropil molecular phenotypes after peripheral axotomy.

Authors:  Nichole A Mesnard; Thomas D Alexander; Virginia M Sanders; Kathryn J Jones
Journal:  Exp Neurol       Date:  2010-06-04       Impact factor: 5.330

8.  PACAP-mediated ATP release from rat urothelium and regulation of PACAP/VIP and receptor mRNA in micturition pathways after cyclophosphamide (CYP)-induced cystitis.

Authors:  Beatrice M Girard; Amanda Wolf-Johnston; Karen M Braas; Lori A Birder; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2008-06-19       Impact factor: 3.444

9.  High-resolution characterization of a PACAP-EGFP transgenic mouse model for mapping PACAP-expressing neurons.

Authors:  Michael C Condro; Anna Matynia; Nicholas N Foster; Yukio Ago; Abha K Rajbhandari; Christina Van; Bhavaani Jayaram; Sachin Parikh; Anna L Diep; Eileen Nguyen; Victor May; Hong-Wei Dong; James A Waschek
Journal:  J Comp Neurol       Date:  2016-06-03       Impact factor: 3.215

10.  Expression of PACAP-like compounds during the caudal regeneration of the earthworm Eisenia fetida.

Authors:  Eszter Varhalmi; Ildiko Somogyi; Gabor Kiszler; Jozsef Nemeth; Dora Reglodi; Andrea Lubics; Peter Kiss; Andrea Tamas; Edit Pollak; Laszlo Molnar
Journal:  J Mol Neurosci       Date:  2008-07-12       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.